Register
Login:
Share:
Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018


Member Info for Simon_Said


Send a private message to Simon_Said

Member Since: Fri, 13th Jan 2017

Number of Share Chat Posts (all time): 2,196
Number of Share Chat Posts (last 30 days): 244

Last Posted: Today 19:29


Post Distribution over the last 30 days




Today 19:29

Somebody here asked RP about the PoO assumption and he confirmed it was based on the CPR which indeed used $47. I can't be bothered to scroll back tens of pages to find the post, if anyone has a bit of caffeine energy they might go and remind us of who it was that checked this! Unless that person is reading this in which case speak up!
Today 18:04

The great thing about RBD's business model is that they are committed to near-term prospects, and acquiring many of them. This means there will always be fuel for SP growth nearby, and no single drill failure can tank it. The whole design is to be shareholder accretive.

There's a reason 2 experienced M&G analysts start their own company and get funding from top institutions. This is a novel strategy that only an experienced BoD with links can pull off.

Malcy is very intrigued by this model too, for what it's worth.
Today 17:57

Quite a list there! Shows the calibre of the BoD here, they have the contacts and trust to garner all that institutional investment. Some very serious names.
Today 17:54

And that's just flow rates. Presentation made it clear we should expect DTU developments at some point, that is certainly not to be counted out. I liked the confirmation that we're funded for all near-term operations. Didn't just say East Denver...
Today 17:26

Crikey. Some in here need to lighten up.

Perhaps when we pass 40p we won't have such crankiness.
Today 17:19

Oh just noticed the subject. Not even discussing PXOG. Lol. This board is going to look very different once the herd arrives.
Today 17:16

Most pi's value a share based on the directors, assets, liabilities, share price situation etc... And then take a stake of an amount of money that affords some shares.

They are not particularly bothered about number in issue. A rather desperate deramp.
Today 14:04

OH COCK NOT THIS AGAIN!

HNR ISN'T ON AIM
HNR ISN'T ON AIM
HNR ISN'T ON AIM
HNR ISN'T ON AIM
HNR ISN'T ON AIM
HNR ISN'T ON AIM
HNR ISN'T ON AIM
HNR ISN'T ON AIM
HNR ISN'T ON AIM
HNR ISN'T ON AIM
HNR ISN'T ON AIM
HNR ISN'T ON AIM

WILL THAT DO???
Today 14:01

Fadec mentioned the 'headroom shares'. I hadn't noticed this. The corporate presentation is here:

http://highlandsnr.com/wp-content/uploads/2017/10/Highlands-4Q17-Market-Update-13.11.17-Final.pdf

On page 20 it mentions 11,304,617 of 'headroom shares'. The investor from last Friday got 11,304,616.

Does anybody know what 'headroom shares' are, why they need admission to AIM if they're already extant, why the investor would have taken all-but-1 of the shares, and most importantly - what all this means?
Today 13:44

Worth remembering that when investors with short positions feel the bottom has been found, we get a short squeeze. I think that looks like happening today. Plenty were short AST so we'll see some decent buys as the shorts close. The turnaround is magnified.

Plenty of momentum here.


Sign up for Live Prices
Top Recommended
Hot Chat Topics
Top recommended posters in the last 30 days
Wassatt2,342
Lakshmi8882,294
kenny1001,715
only1neuron1,680
Troajan1,421
MisterPositive955
langtro951
applegarth845





Member Login

Forgotten your password?
Email:

Password:


Don't have an account? Click here to Register Free!




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.